|
C4ORF46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.49460485391273E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13090000089622E-08 |
| Normal-vs-Stage2 |
7.201900E-03 |
| Normal-vs-Stage3 |
1.856540E-03 |
| Normal-vs-Stage4 |
3.943700E-02 |
| Stage1-vs-Stage2 |
5.418200E-01 |
| Stage1-vs-Stage3 |
9.772800E-01 |
| Stage1-vs-Stage4 |
7.554600E-01 |
| Stage2-vs-Stage3 |
6.566600E-01 |
| Stage2-vs-Stage4 |
5.558800E-01 |
| Stage3-vs-Stage4 |
7.643800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82740045318042E-10 |
| Normal-vs-AfricanAmerican |
2.49689999999303E-05 |
| Normal-vs-Asian |
1.449980E-01 |
| Caucasian-vs-AfricanAmerican |
6.011200E-01 |
| Caucasian-vs-Asian |
3.077800E-01 |
| AfricanAmerican-vs-Asian |
3.899000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.82660039608152E-10 |
| Normal-vs-Female |
8.51320000050393E-08 |
| Male-vs-Female |
4.607600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.82790000000144E-05 |
| Normal-vs-Extreme_Weight |
3.11630000005003E-06 |
| Normal-vs-Obese |
9.97350000031538E-07 |
| Normal-vs-Extreme_Obese |
1.547810E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.973400E-01 |
| Normal_Weight-vs-Obese |
1.570780E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.573000E-01 |
| Extreme_Weight-vs-Obese |
3.379600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.761200E-01 |
| Obese-vs-Extreme_Obese |
2.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.336700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.58499888161623E-11 |
| Normal-vs-Age(61-80Yrs) |
4.31629999964045E-07 |
| Normal-vs-Age(81-100Yrs) |
1.369030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.388000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.691200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.409430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.023800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.867900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.521400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64601665630926E-12 |
| Normal-VS-Type2 PRCC |
3.317800E-01 |
| Normal-VS-KIRP CIMP |
1.376040E-02 |
| Normal-VS-Unclassified PRCC |
8.06970000000184E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.03459471492806E-12 |
| Type1 PRCC-VS-KIRP CIMP |
8.558600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.866800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.628000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.044500E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.582600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.182300E-04 |
| Normal-vs-N1 |
5.482300E-03 |
| Normal-vs-N2 |
3.939900E-03 |
| N0-vs-N1 |
1.555200E-01 |
| N0-vs-N2 |
4.710200E-01 |
| N1-vs-N2 |
8.102000E-01 |
|
|
